Daily supplements of conjugated linoleic acid (CLA) may benefit
intestinal health, suggests new data from a study with Crohn’s disease.
Results of a pilot study with 13 people with Crohn’s disease indicated
that daily supplements with CLA were associated with a suppression of
pro-inflammatory compounds, decreased disease activity and an improved
quality of life.
Crohn’s disease is a chronic relapsing immune-inflammatory disease
involving the gastrointestinal tract. The causes of the disease are
largely unknown although there is increasing evidence of an interplay
between genetic factors, environmental triggers and immune
dysregulation.
«CLA represents a promising new supportive intervention for gut inflammation,» wrote the researchers.
«The present study has shed new light on the clinical potential of this
compound and provided insights on the possible mechanisms of immune
modulation targeted by CLA in the human system.»
CLA is a fatty acid naturally present in ruminant meat and dairy
products. Due to changes in the Western diet, average intake of CLA has
fallen; if the fat is removed from a dairy product to make a low fat
version that will be acceptable to consumers, CLA is removed along with
it.
The ingredient was recently highlighted as a nutrient with a «key» role
to play in the global weight management market. The ingredient is most
often found as a mixture of isomers: cis-9, trans-11 and trans-10,
cis-12
Category: Productos
Source: Nutraingredients